Skip to content

Autologous Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstruction: Comparison of arterial End-to-Side versus End-to-End Anastomosis

Autologous Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstruction: Comparison of arterial End-to-Side versus End-to-End Anastomosis - DIEP-ES Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032948
Enrollment
60
Registered
2023-10-27
Start date
2023-02-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autologous DIEP flap breast reconstruction following mastectomy as part of breast cancer therapy.

Interventions

Group 1: Control intervention: End-to-End anastomosis of the DIEP-flap artery and the internal mammary artery (IMA) Group 2: Experimental intervention: End-to-Side anastomosis of the DIEP-flap arte

Sponsors

BG Klinik Ludwigshafen
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 18 years of age or above, Ability to communicate, Ability to understand the nature and individual consequences of the study,Complete written informed consent, Unilateral Deep Inferior Epigastric Perforator (DIEP) flap breast reconstruction planned, History of breast cancer with mastectomy or prophylactic mastectomy

Exclusion criteria

Exclusion criteria: Patient has a legal guardian, Bilateral DIEP flap planned, History of blood clotting disorder, History of thrombosis-promoting secondary diseases (vasculitis, collagenosis), History of pulmonary embolism/thrombosis

Design outcomes

Primary

MeasureTime frame
Major surgical complication of the recipient (i.e. breast) site, defined as the occurrence of any of the following: a)Microsurgical complications: anastomotic insufficiency, arterial thrombosis b)Hematoma c)Partial or total flap loss d)Reoperation for any of the above and for, but not limited to, wound dehiscence, necrosis, infection

Secondary

MeasureTime frame
Abdominal perfusion, calculated as the: relative difference between the preoperative and postoperative NIR perfusion Index and StO2% (day 1,3 and 5) measured with hyperspectral imaging Major surgical complication of the donor (i.e. abdominal) site, defined as the occurrence of any of the following: a) Skin or adipose tissue necrosis b) Wound dehiscence c) Hematoma d) Seroma e) Hernia or abdominal bulge f) Infection g) Reoperation for, but not limited to, any of the above Patient satisfaction, measured using the: a) SF-36 b) BREAST-Q (reconstruction module) before and 12 months after surgery

Countries

Germany

Contacts

Public ContactAmir Bigdeli

BG Klinik Ludiwgshafen

amir.bigdeli@gmx.de+4962168108926

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026